BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
188 hedge funds and large institutions have $2.67B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2019 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 69 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 69
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
Holders
188
Holding in Top 10
12
Calls
$216M
Puts
$48.3M
Top Buyers
| 1 | +$82.1M | |
| 2 | +$64M | |
| 3 | +$27.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.8M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$21.8M |
Top Sellers
| 1 | -$36.7M | |
| 2 | -$36.5M | |
| 3 | -$21.9M | |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$20.8M |
| 5 |
TAL
TIG Advisors LLC
New York
|
-$19.2M |